Gilman Hill Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Gilman Hill Asset Management's GILD Position: Q3 2020 in Review
Gilman Hill Asset Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,750 shares — an estimated $212K sold.
Gilman Hill Asset Management first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $346K in Q1 2019. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Gilman Hill Asset Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Gilman Hill Asset Management sold 2,750 Gilead Sciences shares in Q3 2020, an estimated $212K.
- Gilman Hill Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
- Gilman Hill Asset Management's Gilead Sciences position peaked at $346K in Q1 2019.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Gilman Hill Asset Management's 13F filing for Q3 2020, filed 16 Oct 2020.